Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Amylyx Pharmaceuticals (AMLX) Depreciation & Amortization (IS) (2024 - 2025)

Amylyx Pharmaceuticals has reported Depreciation & Amortization (IS) over the past 2 years, most recently at $100000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (IS) at $100000.0 for Q4 2025, down 50.0% from a year ago — trailing twelve months through Dec 2025 was $500000.0 (down 44.44% YoY), and the annual figure for FY2025 was $500000.0, down 44.44%.
  • Depreciation & Amortization (IS) for Q4 2025 was $100000.0 at Amylyx Pharmaceuticals, roughly flat from $100000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for AMLX hit a ceiling of $300000.0 in Q1 2024 and a floor of $100000.0 in Q2 2025.